Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 3062759, 7 pages
https://doi.org/10.1155/2017/3062759
Research Article

Association between Cullin-3 Single-Nucleotide Polymorphism rs17479770 and Essential Hypertension in the Male Chinese Han Population

1School of Bioscience and Bioengineering, South China University of Technology, Guangzhou, China
2Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China
3Department of Nephrology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China
4Futian District Chronic Disease Prevention and Cure Center, Shenzhen, China

Correspondence should be addressed to Lei Shi; moc.361@129226ihsycul and Shujin Zhao; moc.361@shzjszzg

Received 25 March 2017; Revised 23 May 2017; Accepted 25 May 2017; Published 18 July 2017

Academic Editor: Zhongjie Shi

Copyright © 2017 Jin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Scott, D. Y. Rhee, D. M. Duda et al., “Two distinct types of E3 ligases work in unison to regulate substrate ubiquitylation,” Cell, vol. 166, article e24, pp. 1198–1214, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Arroyo and G. Gamba, “Advances in WNK signaling of salt and potassium metabolism: clinical implications,” American Journal of Nephrology, vol. 35, no. 4, pp. 379–386, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. F. R. Schumacher, F. J. Sorrell, D. R. Alessi, A. N. Bullock, and T. Kurz, “Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation,” The Biochemical Journal, vol. 460, no. 2, pp. 237–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Boyden, M. Choi, K. A. Choate et al., “Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities,” Nature, vol. 482, no. 7383, pp. 98–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. McCormick, C. L. Yang, C. Zhang et al., “Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3,” The Journal of Clinical Investigation, vol. 124, pp. 4723–4736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Tan, “Changing disease trends in the Asia-Pacific,” Climacteric, vol. 14, pp. 529–534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Weiwei, G. Runlin, L. Lisheng et al., “Cardiovascular disease Chinese report 2015 summary,” Chinese Circulation Journal, vol. 31, pp. 617–622, 2015. View at Google Scholar
  8. C. Fava, M. Ricci, O. Melander, and P. Minuz, “Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: a sex-specific relation,” Prostaglandins & Other Lipid Mediators, vol. 98, no. 3-4, pp. 75–85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Kunes and J. Zicha, “Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist’s view,” Clinical Science (London), vol. 111, no. 5, pp. 295–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Fu, T. Nakayama, N. Sato et al., “Haplotype-based case-control study of CYP4A11 gene and myocardial infarction,” Hereditas, vol. 149, no. 3, pp. 91–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. K. Pandey, G. Agarwal, S. M. Kale et al., “Development and evaluation of a high density genotyping ‘Axiom_Arachis’ array with 58 K SNPs for accelerating genetics and breeding in groundnut,” Scientific Reports, vol. 7, article 40577, 2017. View at Google Scholar
  12. M. Lu, X. Wang, F. Wang et al., “WNK4 polymorphisms and essential hypertension in the Uyghur population,” Clinical and Experimental Hypertension, vol. 31, no. 2, pp. 179–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Cun, J. Li, W. Tang et al., “Association of WNK1 exon 1 polymorphisms with essential hypertension in Hani and Yi minorities of China,” Journal of Genetics and Genomics, vol. 38, no. 4, pp. 165–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. J. Sun, Y. Li, J. Y. Lu et al., “Association of Ala589Ser polymorphism of WNK4 gene with essential hypertension in a high-risk Chinese population,” The Journal of Physiological Sciences, vol. 59, no. 2, pp. 81–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sheth, J. L. Weissfeld, M. Romkes et al., “Germline Variation in NFE2L2/CUL3/KEAP1 and Risk of Head and Neck Squamous Cell Carcinoma (HNSCC),” Journal of Clinical Oncology, vol. 33, Supplement 15, p. 1540, 2015. View at Google Scholar
  16. S. R. Ibeawuchi, L. N. Agbor, F. W. Quelle, and C. D. Sigmund, “Hypertension-causing mutations in cullin3 protein impair RhoA protein ubiquitination and augment the association with substrate adaptors,” The Journal of Biological Chemistry, vol. 290, pp. 19208–19217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Padmanabhan, O. Melander, T. Johnson et al., “Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension,” PLoS Genetics, vol. 6, no. 10, article e1001177, 2010. View at Google Scholar
  18. B. Mayer, W. Lieb, A. Götz et al., “Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy,” Hypertension, vol. 46, no. 4, pp. 766–771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Levy, G. B. Ehret, K. Rice et al., “Genome-wide association study of blood pressure and hypertension,” Nature Genetics, vol. 41, no. 6, pp. 677–687, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. C. Yan, J. H. Liu, J. Li et al., “Association between the CYP4A11 T8590C variant and essential hypertension: new data from Han Chinese and a meta-analysis,” PLoS One, vol. 8, no. 11, article e80072, 2013. View at Google Scholar
  21. B. Xiao, Y. Zhang, W. Niu, P. Gao, and D. Zhu, “Association of ATP1B1 single-nucleotide polymorphisms with blood pressure and hypertension in a Chinese population,” Clinica Chimica Acta, vol. 407, no. 1-2, pp. 47–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, X. O. Zhou, Y. Zhang, P. J. Gao, and D. L. Zhu, “Association of the CD36 gene with impaired glucose tolerance, impaired fasting glucose, type-2 diabetes, and lipid metabolism in essential hypertensive patients,” Genetics and Molecular Research, vol. 11, no. 3, pp. 2163–2170, 2012. View at Publisher · View at Google Scholar
  23. Q. Zhu, Z. Y. Fu, and Y. T. Ma, “GW25-e3132 single nucleotide polymorphism of the CYP2J2 gene is associated with essential hypertension in Uygur population in China,” Journal of the American College of Cardiology, vol. 4, no. 1, article C9, 2014. View at Google Scholar
  24. C. L. Laffer, J. V. Gainer, M. R. Waterman et al., “The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension,” Hypertension, vol. 51, no. 3, pp. 767–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Yang, Z. Fu, Y. Ma et al., “CYP4A11 gene T8590C polymorphism is associated with essential hypertension in the male western Chinese Han population,” Clinical and Experimental Hypertension, vol. 36, no. 6, pp. 398–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. D. E. Stec, R. J. Roman, A. Flasch, and M. J. Rieder, “Functional polymorphism in human CYP4F2 decreases 20-HETE production,” Physiological Genomics, vol. 30, no. 1, pp. 74–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. G. Moraitis, W. E. Rainey, and R. J. Auchus, “Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension,” The Application of Clinical Genetics, vol. 7, pp. 1–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Yu, S. H. Keller, C. V. Remillard et al., “A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension,” Circulation, vol. 119, no. 17, pp. 2313–2322, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” Jama, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. James, S. Oparil, B. L. Carter et al., “2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8),” Journal of the American Medical Association, vol. 311, no. 5, pp. 507–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Gong, J. Wang, J. Yang, E. Gonzales, R. Perez, and J. Hou, “KLHL3 regulates paracellular chloride transport in the kidney by ubiquitination of claudin-8,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, pp. 4340–4345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. X. Ji and G. G. Privé, “Crystal structure of KLHL3 in complex with cullin3,” PLoS One, vol. 8, no. 4, article e60445, 2013. View at Google Scholar
  33. J. A. McCormick and D. H. Ellison, “The WNKs: atypical protein kinases with pleiotropic actions,” Physiological Reviews, vol. 91, no. 1, pp. 177–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. K. T. Kahle, A. M. Ring, and R. P. Lifton, “Molecular physiology of the WNK kinases,” Annual Review of Physiology, vol. 70, pp. 329–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. K. B. Gagnon and E. Delpire, “Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport,” Physiological Reviews, vol. 92, no. 4, pp. 1577–1617, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Gamba, “The thiazide-sensitive Na+-Cl cotransporter: molecular biology, functional properties, and regulation by WNKs,” American Journal of Physiology. Renal Physiology, vol. 297, no. 4, pp. F838–F848, 2009. View at Google Scholar
  37. C. Richardson, K. Sakamoto, P. de los Heros et al., “Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways,” Journal of Cell Science, vol. 124, Part 5, pp. 789–800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. C. Vitari, J. Thastrup, F. H. Rafiqi et al., “Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1,” The Biochemical Journal, vol. 397, no. 1, pp. 223–231, 2006. View at Publisher · View at Google Scholar · View at Scopus